Skip to content
★ Sign in to follow
ET

Eddie Thordarson

A1M Pharma
Total declarations
2
Company
1
▲ Purchases (1 ops.)
€1,325
▼ Sales (0 ops.)
—

Latest filing published 08 Dec 2017 for A1M Pharma, €1,501.

Filing timeline

BuySale
Eddie Thordarson

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Eddie Thordarson: trading record in brief

Eddie Thordarson discloses dealings in A1M Pharma to Finansinspektionen. In total, 2 filings cover trades dated from 19 October 2017 to 8 December 2017.

The open-market record is one-sided, with 1 purchase worth €1,325 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

On 8 December 2017 came the latest disclosure, a transaction for €1,501 in A1M Pharma. The last insider purchase was made public on 19 October 2017, 3,306 days ago. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Eddie Thordarson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    UtvecklingschefExecutivesA1M Pharma
    15,000 SEK7FI-SE
    1,000 shares@ SEK 15.0053.1% of flowISIN SE0009773450FI:csv-b3db882473af50eca9c4
  • ▲
    UtvecklingschefExecutivesA1M Pharma
    12,757 SEK7FI-SE
    1,277 shares@ SEK 9.9946.9% of flowISIN SE0005876828FI:csv-c3c385d004a82395d5f6
    Canonical exit: 17 Jan 2018 (T+90)

2 of 2 declarations